AU2004902190A0 - Pharmaceutical Formulation - Google Patents

Pharmaceutical Formulation

Info

Publication number
AU2004902190A0
AU2004902190A0 AU2004902190A AU2004902190A AU2004902190A0 AU 2004902190 A0 AU2004902190 A0 AU 2004902190A0 AU 2004902190 A AU2004902190 A AU 2004902190A AU 2004902190 A AU2004902190 A AU 2004902190A AU 2004902190 A0 AU2004902190 A0 AU 2004902190A0
Authority
AU
Australia
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004902190A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayne Pharma Pty Ltd
Original Assignee
Mayne Pharma Pty Ltd
Filing date
Publication date
Application filed by Mayne Pharma Pty Ltd filed Critical Mayne Pharma Pty Ltd
Publication of AU2004902190A0 publication Critical patent/AU2004902190A0/en
Priority to PCT/AU2005/000587 priority Critical patent/WO2005102312A1/en
Abandoned legal-status Critical Current

Links

AU2004902190A 2004-04-27 2004-04-27 Pharmaceutical Formulation Abandoned AU2004902190A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2005/000587 WO2005102312A1 (en) 2004-04-27 2005-04-27 Concentrated oxaliplatin solutions

Publications (1)

Publication Number Publication Date
AU2004902190A0 true AU2004902190A0 (en) 2004-05-13

Family

ID=

Similar Documents

Publication Publication Date Title
EP1773768B8 (en) Pyrrole derivatives as pharmaceutical agents
IL177566A0 (en) Pharmaceutical formulations
GB0426301D0 (en) Pharmaceutical formulations
AU2003901813A0 (en) Pharmaceutical derivatives
AU2002364468A1 (en) Solid orally-dispersible pharmaceutical formulation
GB0423565D0 (en) Formulation
GB0316206D0 (en) Pharmaceutical formulation
GB0412530D0 (en) Formulation
HK1105358A1 (en) Solid pharmaceutical formulation
GB0416397D0 (en) Pharmaceutical formulations
GB0423800D0 (en) New pharmaceutical formulations
GB0425255D0 (en) Pharmaceutical composition
GB0406048D0 (en) Drug formulations
EP1716865A4 (en) Paraoxonase-containing pharmaceutical preparation
AU2004902190A0 (en) Pharmaceutical Formulation
AU2005903196A0 (en) Pharmaceutical formulation
AU2005904737A0 (en) Drug formulation
AU2003904627A0 (en) Pharmaceutical Formulation
AU2004901779A0 (en) Pharmaceutical composition
GB0418270D0 (en) Pharmaceutical formulation
GB0422111D0 (en) Pharmaceutical formulation
GB0310881D0 (en) Pharmaceutical formulation
GB0417042D0 (en) Stable pharmaceutical formulation
AU2003238900A1 (en) Pharmaceutical formulation
AU2004900318A0 (en) Medicinal composition